| Financial Year |
March 31 2023 |
| Monetary Funds |
1,409,370,992.98 |
| Held-for-trading Financial Assets |
70,294,911.37 |
| Notes Receivable |
223,973,893.81 |
| Accounts Receivable |
1,006,800,467.31 |
| Advances to Suppliers |
86,250,898.94 |
| Other Receivables |
136,907,060.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
439,763,438.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,361,813.30 |
| Total Current Assets |
3,881,421,805.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,661,351.63 |
| Long-term Equity Investment |
341,074,716.68 |
| Investment Properties |
625,994,986.53 |
| Fixed Assetes |
392,722,846.54 |
| Under-construction Projects |
38,986,220.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
73,915,271.39 |
| R&D expenses |
39,294,432.67 |
| Goodwill |
253,293,313.57 |
| Long-Term Deferred and Prepaid Expenses |
15,913,679.41 |
| Deferred Income Tax Assets |
54,663,962.00 |
| Other Non-Current Assets |
7,920,000.00 |
| Sub-Total of Non-Current Assets |
2,169,064,923.80 |
| Total Assets |
6,050,486,729.08 |
| Short-Term Loans |
76,617,092.87 |
| Trading Financial liabilities |
-- |
| Notes Payable |
71,934,525.34 |
| Accounts Payable |
801,514,495.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
109,204,327.67 |
| Taxes Payable |
16,132,493.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
195,292,096.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,126,708.57 |
| Other Current Liabilities |
24,155,110.41 |
| Sub-Total of Current Liabilities |
2,152,324,867.98 |
| Long-term Loans |
185,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,571,822.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
251,487,210.50 |
| Total Liabilities |
2,403,812,078.48 |
| Paid-In Capital(Or Share Stock) |
1,727,590,595.00 |
| Capital Surplus |
2,593,269,942.96 |
| Surplus Reserve |
50,173,507.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-974,186,758.59 |
| Minority Stockholder's Interest |
282,024,697.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,364,649,952.90 |
| Owner's Equity（Stockholder's Equity） |
3,646,674,650.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,050,486,729.08 |
